Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxyd ecyl)-1 ,4benzoquinone for the treatment of muscular dystrophies

Details for Australian Patent Application No. 2006226623 (hide)

Owner Santhera Pharmaceuticals (Schweiz) AG

Inventors Meier, Thomas; Buyse, Gunnar

Agent Shelston IP

Pub. Number AU-B-2006226623

PCT Pub. Number WO2006/100017

Priority 05006137.3 21.03.05 EP

Filing date 20 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 22 April 2010

International Classifications

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

8 November 2007 PCT application entered the National Phase

  PCT publication WO2006/100017 Priority application(s): WO2006/100017

22 April 2010 Application Accepted

  Published as AU-B-2006226623

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226624-Polysiloxane coated metal oxide particles

2006226615-CGRP antagonists, method for the production thereof, and their use as medicaments